Copyright
©The Author(s) 2022.
World J Transplant. Mar 18, 2022; 12(3): 42-54
Published online Mar 18, 2022. doi: 10.5500/wjt.v12.i3.42
Published online Mar 18, 2022. doi: 10.5500/wjt.v12.i3.42
Table 1 Management for hypertension following renal transplantation
| Blood pressure management | Interventions | Comments |
| Non-pharmacological management | Dietary sodium restriction; Weight reduction; Exercise; Smoking cessation; Stress reduction | |
| Pharmacological therapy | Antihypertensive medications: -Diuretics; -Calcium channel blockers; -Beta-blockers; -Renin-angiotensin aldosterone system blockade; -Alpha1 antagonists; -Alpha 2 agonists | Medication choice depends on patient characteristics, adverse effects, tolerability |
| Invasive interventions | -Transplant renal artery angioplasty +/- stenting; -Continuous positive airway pressure; -Bilateral native nephrectomy; -Native renal denervation | -Transplant renal artery stenosis; -Obstructive sleep apnea; -Failed native kidney; -Sympathetic overactivity |
| Adjustment of Immunosuppressive Medication | -Steroid withdrawal protocol; -Minimize dose of calcineurin inhibitors; -Replace CsA by using less hypertensive and less nephrotoxic drugs | Other drugs that can be used: -MMF: Mycophenolate mofetil; -Tacrolimus; -Sirolimus |
- Citation: Nassar M, Nso N, Lakhdar S, Kondaveeti R, Buttar C, Bhangoo H, Awad M, Sheikh NS, Soliman KM, Munira MS, Radparvar F, Rizzo V, Daoud A. New onset hypertension after transplantation. World J Transplant 2022; 12(3): 42-54
- URL: https://www.wjgnet.com/2220-3230/full/v12/i3/42.htm
- DOI: https://dx.doi.org/10.5500/wjt.v12.i3.42